|
|
|
|
|
非在研适应症- |
最高研发阶段批准上市 |
|
首次获批日期1991-12-11 |
A Phase IV interventional post approval trial to investigate effectiveness and safety of vericiguat therapy in Indian patients with chronic heart failure with reduced ejection fraction after a worsening heart failure event. - VERINA
A Phase IV interventional post approval trial to assess the safety of intravitreal aflibercept for the treatment of diabetic macular edema (DME) in patients in India. - VISION AF
A Real-World, Prospective, Observational Study to Evaluatethe Safety and Effectiveness of Rivaroxaban (Xarelto®) forPrevention of Stroke and Systemic Embolism in IndianPatients with Non-valvular Atrial Fibrillation (NVAF) - XARIN
100 项与 Bayer Zydus Pharma Pvt Ltd. 相关的临床结果
0 项与 Bayer Zydus Pharma Pvt Ltd. 相关的专利(医药)
100 项与 Bayer Zydus Pharma Pvt Ltd. 相关的药物交易
100 项与 Bayer Zydus Pharma Pvt Ltd. 相关的转化医学